An agent including an analog wherein the native gelonin cysteine residues at positions 44 and 50 arereplaced with non-cysteine residues, such as alanine is preferred.An agent according to the present invention may include an analog of barley ribosome-inactivating protein, preferably an analog wherein the cysteine is at a position in the analog from position 260 to the carboxyl terminal position of